- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Human Epidermal Growth Factor Receptor 2-negative (HER2-) breast cancer
Total 145273 results
-
Baylor College of MedicineThe Methodist Hospital Research InstituteRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Pancreatic Adenocarcinoma | Lung Cancer | Solid Tumor | Bladder Cancer | Head and Neck Squamous Cell Carcinoma | Cancer of the Salivary GlandUnited States
-
Consorzio OncotechCompleted
-
Second Military Medical UniversityUnknown
-
BayerCompletedCancers With HER2 ExpressionUnited States, United Kingdom
-
Seagen Inc.Array BioPharmaCompleted
-
Spanish Breast Cancer Research GroupRoche Farma, S.ACompleted
-
University of Kansas Medical CenterPfizerTerminatedHER2-positive Breast Cancer | Breast Cancer MetastaticUnited States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
Spectrum Pharmaceuticals, IncTerminatedBreast Cancer | Colorectal Cancer | Solid Tumor | Glioblastome MultiformeUnited States
-
Genentech, Inc.Completed
-
SCRI Development Innovations, LLCSeagen Inc.Recruiting
-
SOLTI Breast Cancer Research GroupNovartisCompleted
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
RemeGen Co., Ltd.Completed
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.RecruitingMetastatic Lung Non-Small Cell Carcinoma | Refractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8 | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8United States
-
Universitair Ziekenhuis BrusselKom Op Tegen Kanker; Agentschap voor Innovatie door Wetenschap en Technologie...RecruitingGastric Cancer | Colorectal Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Endometrial Cancer | Urothelial Carcinoma | Biliary Tract Cancer | Locally Advanced Breast Cancer | Cancer of Pancreas | Uterine Cancer | Salivary Gland Cancer | Metastatic Breast Carcinoma | Solid Tumor With Intermediate...Belgium
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHER2-positive Breast CancerChina
-
Vardhman Mahavir Medical College And Safdarjung...Completed
-
Peking University People's HospitalRecruitingHER2-negative Early Breast CancerChina
-
Eisai Co., Ltd.Active, not recruiting
-
Institut Català d'OncologiaFundación Sociedad Española de Oncologia Médica; Instituto de Salud Carlos III and other collaboratorsRecruitingNeoplasms | Breast Cancer | HER2-positive Breast CancerSpain
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Poland, Taiwan, Thailand, Canada, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, China, Saudi Arabia, Russian Federation, Bulgaria
-
Renske AltenaTerminatedHER2-positive Breast Cancer | Early-stage Breast CancerSweden
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruitingHR-positive, HER2-negative Breast NeoplasmsChina
-
GlaxoSmithKlineCompleted
-
Alphamab (Australia) Co Pty Ltd.RecruitingAdvanced Solid Tumors | Metastatic Solid TumorsAustralia
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.CompletedNon-Small Cell Lung CancerUnited States, Spain, Japan, Netherlands, France
-
Anne Arundel Health System Research InstituteGenentech, Inc.Unknown
-
European Organisation for Research and Treatment...Hoffmann-La Roche; UNICANCER; Janssen Diagnostics, LLC; SUCCESSCompletedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Circulating Tumor CellsFrance, Germany, Belgium, United Kingdom
-
Atossa Therapeutics, Inc.InClinRecruitingBreast Neoplasms | Invasive Breast Cancer | HER2-negative Breast Cancer | Estrogen-receptor-positive Breast CancerUnited States
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingHER2-positive Breast CancerChina
-
University of WashingtonUnited States Department of DefenseRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Hoffmann-La RocheCompletedHER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast CancerIndia
-
Virginia Commonwealth UniversityEli Lilly and Company; BayerTerminatedBreast Cancer | Metastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
Zhi YangWithdrawnGlioma | Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung CancerChina
-
Merus N.V.CompletedBreast Cancer MetastaticUnited States, France, Belgium, Spain, United Kingdom, Netherlands, Portugal
-
Shen LinUnknownColorectal Cancer | Esophageal Squamous Cell Carcinoma | Biliary Tract Cancer | Targeted Therapy | HER2China
-
Esanex Inc.Terminated
-
Peking Union Medical College HospitalCompletedBreast CancerChina
-
First People's Hospital of HangzhouMacera therapeuticsNot yet recruiting
-
Karolinska University HospitalRecruitingBreast Cancer | Esophageal Neoplasms | HER2-positive Gastric Cancer | Gastric Neoplasms MalignantSweden
-
University of ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
National Cancer Institute (NCI)CompletedBreast Cancer | Breast Neoplasms | Adenocarcinomas | Metastatic Solid Tumors Characterized by HER2/Neu ExpressionUnited States
-
Guangdong Academy of Medical SciencesGuangzhou First People's Hospital; Guangzhou General Hospital of Guangzhou... and other collaboratorsUnknownHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastChina
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.Active, not recruitingBreast CancerChina, United States, Spain, Hungary, Israel, Korea, Republic of, Taiwan, Belgium, Austria, Russian Federation, Switzerland, Portugal, France, Canada, Italy, United Kingdom, Greece, Japan, Germany, Sweden
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
GlaxoSmithKlineTerminatedNeoplasmsUnited States, Korea, Republic of, Canada, Spain, Australia, United Kingdom, France
-
PrecirixCompleted
-
Eisai Inc.Bliss Biopharmaceutical (Hangzhou) Co., LtdRecruiting